Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…

At ASH 2023, there is a discussion with Dr. Davide Matino, Assistant Professor of Medicine at…

By. Terry Mamounas Date: 12/07/2023In a collaborative study between NVP and RT, led by oncologist…

By. Saranya Chumsri, MD Date: 12/12/2023 Saranya Chumsri, MD, an expert in the field of…

Jeff Sharman, MD, a medical oncologist at the Willamette Ballet Cancer Institute and Research Center,…

Hamish Scott, MD, serves as the Head of the Department of Genetics and Molecular Pathology…

At ASH 2023, Hamza Hashmi, MD, a medical doctor and hematologist from Charleston, South Carolina,…

By: Melinda Telli, MD, Date: 12/9/2023 At the SABCS 2023 conference, we had the privilege…

At ASH 2023, Ola Landgren, MD, Professor of Medicine and Chief Division of Myeloma at…

In the groundbreaking study conducted by Bruce Feinberg,DO, Chief Medical Officer at Cardinal Health, the…